AcuCort obtains trademark protection for Zeqmelit® in India
AcuCort AB announces that the trademark for the company's drug Zeqmelit® has been registered for trademark protection in India.The trademark protection is of strategic importance as the company enters the commercialization phase. "It is very gratifying that we have now obtained trademark protection in India for our oral film Zeqmelit® and its associated applications. This is an important step towards commercialization in India," says Jonas Jönmark”, CEO of AcuCort. The trademark protection for Zeqmelit® in India is valid for the next 10 years, after which the company must apply for an